default author photo

Luke Tzu Chi Liu

Medigen Vaccine Biologics Corp.

SCHOLARLY PAPERS

2

DOWNLOADS

199

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Phase I, Prospective, Randomized, Open-Labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults

Number of pages: 26 Posted: 09 Sep 2022
Medigen Vaccine Biologics Corp., Taipei Medical University - Clinical Research Centre, National Defense Medical Center - Tri-Service General Hospital, Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Chang Gung University - Research Center for Emerging Viral Infections and Medigen Vaccine Biologics Corp.
Downloads 105 (664,543)

Abstract:

Loading...

COVID-19, SARS-CoV-2, SARS-CoV-2 vaccine, MVC-COV1901, booster vaccination, SARS-CoV-2 Beta variant booster vaccine, Omicron variant

2.

Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study

Number of pages: 25 Posted: 22 Jul 2024
MacKay Children’s Hospital - Department of Paediatrics, Hsinchu MacKay Memorial Hospital - Department of Paediatrics, Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Chang Gung University - Molecular Infectious Disease Research Center and National Taiwan University - Department of Paediatrics
Downloads 94 (742,061)

Abstract:

Loading...

Enterovirus, Enterovirus vaccine, EV-A71, EV-A71 vaccine, hand, foot, and mouth disease, pediatrics, clinical trial, immune durability